124467-36-3 Usage
General Description
2-Chloro-7,8-dihydro-6H-quinolin-5-one is a chemical compound that is a derivate of quinolinone, a class of organic compounds commonly used in medicinal and pharmaceutical chemistry due to their ability to display a wide range of biological activities. The presence of a chlorine atom at its second position makes it a potential intermediate for the synthesis of more complex compounds. Its structure involves the combination of a benzene ring and a pyridine ring forming a bicyclic system. While there's not much specific information about its properties or uses, being an organic chemical it usually is a potential candidate for studies in drug synthesis, chemical reactions, and pharmacology. As with all chemicals, careful handling under professional supervision is essential due to potential toxicity or reactivity issues.
Check Digit Verification of cas no
The CAS Registry Mumber 124467-36-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,4,6 and 7 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 124467-36:
(8*1)+(7*2)+(6*4)+(5*4)+(4*6)+(3*7)+(2*3)+(1*6)=123
123 % 10 = 3
So 124467-36-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H8ClNO/c10-9-5-4-6-7(11-9)2-1-3-8(6)12/h4-5H,1-3H2
124467-36-3Relevant articles and documents
SHP2 INHIBITORS, COMPOSITIONS AND USES THEREOF
-
Page/Page column 108-109, (2021/12/30)
Provided are compounds of Formula (I), methods of using the compounds as SHP2 inhibitors, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating SHP2-mediated diseases.
HETEROARYLCARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS
-
Page/Page column 65, (2017/05/21)
The present invention relates to compounds of general formula I, wherein D1 to D3, A, R1, R2, Y and n are defined as in claim 1, which have valuable pharmacological properties, in particular are inhibitors of pl
Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use
-
, (2014/02/16)
The present application relates to novel 5-amino-5,6,7,8-tetrahydroquinoline-2-carboxylic acids, to processes for their preparation, to their use for the treatment and/or prevention of diseases, and to their use for producing medicaments for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular and cardiopulmonary disorders.